Learn About Symptom Relief for Patients with Heart Failure

OSUWexnerbloglogo2014 Learn About Symptom Relief for Patients with Heart Failure. The American Lung Association has a slogan “When you can’t breathe, nothing else matters”. And that is particulary true for patients with end-stage cardiac disease. But the good news is that we have treatment approaches that can help and that is where palliative medicine comes in. I’m pleased to welcomes Associate Professor of Internal Medicine and palliative medicine specialist, Dr. Todd Barrett.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW Palliative Care
Domains; and REVIEW Symptom Burden and Treatment in Heart Failure.

You’ll also learn about the following:

  • Heart conditions that benefit from palliative medicine
  • Opioid selection and strategies for use
  • Opioid side effects
  • Fluid management strategies to improve shortness of breath
  • SGLT2 inhibitors
  • Palliative care versus hospice care
  • Incorporating palliative care into usual cardiac care
  • COVID-19 related challenges in providing palliative care

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About the Medical Management of Heart Failure on CME Webcast

OSUWexnerbloglogo2014 Learn About the Medical Management of Heart Failure on CME Webcast. Heart failure is an indiscriminate villain and can attack the rich and the poor, man or woman, old or young. But the good news is that we have better medical treatments for heart failure than ever before. On this CME Webcast, we’re going to update you about them. Joining our moderator in the studio are two heart failure cardiologists from the Ohio State University. Dr. Ajay Vallakati is an Assistant Professor and Dr. Brent Lampert is an Associate Professor, both from the Department of Internal Medicine.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the mechanism of action and indications for sacubitril-valsartan; UNDERSTAND the mechanism of action and indications for ivabradine; DISCUSS the pharmacological management of heart failure; and RECOGNIZE new heart failure therapies including sacubitril-valsartan and ivabradine as well as understand their role in treating heart failure.

You’ll also learn about the following:

  • New medications to treat heart failure
  • Selecting an ACE inhibitor
  • Selecting a diuretic
  • Diastolic versus systolic heart failure treatment
  • Counseling patients about sodium and fluid intake
  • When to place an automatic implantable cardiac defibrillator
  • Follow-up testing of patients with heart failure

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Update on Adult Congenital Heart Disease

OSUWexnerbloglogo2014 Update on Adult Congenital Heart Disease. On this CME webcast, we’re going to update you on some of the unique challenges of diagnosing and treating adults with congenital heart disease. Joining our moderator in the studio is cardiologist and Assistant Professor of Internal Medicine, Dr. Saurabh Rajpal.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: INCREASE awareness about increasing prevalence of Adult Congenital Heart disease; and DISCUSS common congenital
heart disease diagnoses encountered in adult practice.

You’ll also learn about the following:

  • Common causes of congenital heart disease in adult patients
  • Changing prevalence of congenital heart disease in adults
  • Follow up testing and monitoring
  • Marfan syndrome

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Discusses Pulmonary Hypertension

OSUWexnerbloglogo2014 CME Webcast Discusses Pulmonary Hypertension. Today on MedNet, we’re going to review the causes and diagnosis of pulmonary hypertension as well as the currently available treatments. On this CME webcast, in the studio, are pulmonary hypertension specialists from the Ohio State University. Dr. Shaun Smith is a pulmonologist and Assistant Professor of Internal Medicine. And Dr. Veronica Franco is a cardiologist and Associate Professor of Internal Medicine.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: PROVIDE basic determination if a patient may respond to calcium channel blockers for treatment of pulmonary hypertension; DETERMINE when a patient should be started on parental prostacyclins; DISCUSS the hemodynamic definition, classification and epidemiology of pulmonary arterial hypertension; and REVIEW the signs and symptoms of pulmonary arterial hypertension as well as the diagnostic algorithm.

You’ll also learn about the following:

  • The causes of pulmonary hypertension
  • Which patients should be treated with vasodilators
  • Vasodilator testing during the right heart cath
  • Selecting the right drug
  • Which patients do not benefit by vasodilators?
  • Anticoagulation

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Discover Device Therapies for Heart Failure on Webcast

OSUWexnerbloglogo2014 Discover Device Therapies for Heart Failure on Webcast. In the past, we could prescribe medications or do a heart transplant, but that was about it. Now we have new devices that can help our patients with heart failure. On this CME webcast, we’re going to hear about these new devices to show you how these treatments can help them live longer and better lives. Joining our moderator in the studio are cardiologists and heart failure experts from the Ohio State University. Dr. Rami Kahwash is an Associate Professor of Internal Medicine and he is the Director of the Cardiovascular Research Organization at OSU. And Dr. Sitaramesh Emani is an Assistant Professor of Internal Medicine and the Director of Heart Failure Clinical Trials.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DESCRIBE the primary prevention strategies of the prevention of sudden cardiac death in chronic systolic heart failure and the role of Cardiac Resynchronization therapy (CRT); and UNDERSTAND indications of the new defibrillation strategies (wearable ICD and subcutaneous ICD) in the prevention of sudden cardiac death.

You’ll also learn about the following:

  • Medications versus implantable cardiac defibrillators
  • Implantable cardiac monitoring devices
  • Precautions when caring for patients with a ventricular assist device
  • Complications of ventricular assist devices
  • Investigational devices
  • Current role of the intra-aortic balloon pump

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.